These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29390599)

  • 21. Central nervous system distribution kinetics of indinavir in rats.
    Hamidi M
    J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of antibacterial agents in infections of the central nervous system.
    Thea D; Barza M
    Infect Dis Clin North Am; 1989 Sep; 3(3):553-70. PubMed ID: 2671139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients.
    Myrianthefs P; Markantonis SL; Vlachos K; Anagnostaki M; Boutzouka E; Panidis D; Baltopoulos G
    Antimicrob Agents Chemother; 2006 Dec; 50(12):3971-6. PubMed ID: 16982782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Prospect of Nanoparticle Systems for Modulating Immune Cell Polarization During Central Nervous System Infection.
    Korshoj LE; Shi W; Duan B; Kielian T
    Front Immunol; 2021; 12():670931. PubMed ID: 34248952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.
    DeMarino C; Schwab A; Pleet M; Mathiesen A; Friedman J; El-Hage N; Kashanchi F
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):31-50. PubMed ID: 27372507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood brain barrier and infection.
    Chaudhuri JD
    Med Sci Monit; 2000; 6(6):1213-22. PubMed ID: 11208482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central nervous system penetration of antiretroviral drugs: pharmacokinetic, pharmacodynamic and pharmacogenomic considerations.
    Decloedt EH; Rosenkranz B; Maartens G; Joska J
    Clin Pharmacokinet; 2015 Jun; 54(6):581-98. PubMed ID: 25777740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system.
    Suzuki H; Sawada Y; Sugiyama Y; Iga T; Hanano M; Spector R
    J Pharmacol Exp Ther; 1989 Sep; 250(3):979-84. PubMed ID: 2506338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic pharmacodynamics in cerebrospinal fluid.
    Lutsar I; McCracken GH; Friedland IR
    Clin Infect Dis; 1998 Nov; 27(5):1117-27, quiz 1128-9. PubMed ID: 9827256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacodynamics of antibiotics in CSF: principles and consequences (predictive factors of efficacy)].
    Van Bambeke F; Tulkens PM
    Med Mal Infect; 2009; 39(7-8):483-92. PubMed ID: 19500928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selecting Good 'Drug-Like' Properties to Optimize Small Molecule Blood-Brain Barrier Penetration.
    Trippier PC
    Curr Med Chem; 2016; 23(14):1392-407. PubMed ID: 27048339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The unit impulse response procedure for the pharmacokinetic evaluation of drug entry into the central nervous system.
    van Bree JB; Baljet AV; van Geyt A; de Boer AG; Danhof M; Breimer DD
    J Pharmacokinet Biopharm; 1989 Aug; 17(4):441-62. PubMed ID: 2614681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linezolid in the central nervous system: comparison between cerebrospinal fluid and plasma pharmacokinetics.
    Viaggi B; Paolo AD; Danesi R; Polillo M; Ciofi L; Del Tacca M; Malacarne P
    Scand J Infect Dis; 2011 Sep; 43(9):721-7. PubMed ID: 21585240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Minimal Physiologically Based Pharmacokinetic Model to Characterize CNS Distribution of Metronidazole in Neuro Care ICU Patients.
    Chauzy A; Bouchène S; Aranzana-Climent V; Clarhaut J; Adier C; Grégoire N; Couet W; Dahyot-Fizelier C; Marchand S
    Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study.
    Oberrauch S; Lu J; Cornthwaite-Duncan L; Hussein M; Li J; Rao G; Velkov T
    J Vis Exp; 2022 Mar; (181):. PubMed ID: 35435913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cerebrospinal fluid and barriers - anatomic and physiologic considerations.
    Tumani H; Huss A; Bachhuber F
    Handb Clin Neurol; 2017; 146():21-32. PubMed ID: 29110772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents.
    Waterhouse RN
    Mol Imaging Biol; 2003; 5(6):376-89. PubMed ID: 14667492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The blood-brain barrier and drug delivery in the central nervous system].
    Loch-Neckel G; Koepp J
    Rev Neurol; 2010 Aug; 51(3):165-74. PubMed ID: 20645267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of microdialysis for the study of drug kinetics: central nervous system pharmacokinetics of diphenhydramine in fetal, newborn, and adult sheep.
    Au-Yeung SC; Riggs KW; Gruber N; Rurak DW
    Drug Metab Dispos; 2007 Aug; 35(8):1285-91. PubMed ID: 17485495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.